Page last updated: 2024-08-16
trequinsin and rpl 554
trequinsin has been researched along with rpl 554 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boswell-Smith, V; Comer, MB; Oxford, AW; Page, CP; Seeds, EA; Spina, D | 1 |
Other Studies
1 other study(ies) available for trequinsin and rpl 554
| Article | Year |
|---|---|
The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropy
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Airway Resistance; Animals; Blood Pressure; Bronchoalveolar Lavage Fluid; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Isoquinolines; Lung; Male; Monocytes; Muscle Contraction; Muscle, Smooth; Ovalbumin; Phosphodiesterase Inhibitors; Phytohemagglutinins; Platelet Aggregation Inhibitors; Pneumonia; Pyrimidinones; Tetrahydroisoquinolines; Trachea; Tumor Necrosis Factor-alpha | 2006 |